METHAZOLAMIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Methazolamide, and when can generic versions of Methazolamide launch?
Methazolamide is a drug marketed by Ani Pharms, Applied Anal, Athem, Bausch And Lomb Inc, Mikart, Sandoz, and Tagi. and is included in seven NDAs.
The generic ingredient in METHAZOLAMIDE is methazolamide. There are seven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the methazolamide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Methazolamide
A generic version of METHAZOLAMIDE was approved as methazolamide by ANI PHARMS on June 30th, 1993.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for METHAZOLAMIDE?
- What are the global sales for METHAZOLAMIDE?
- What is Average Wholesale Price for METHAZOLAMIDE?
Summary for METHAZOLAMIDE
| US Patents: | 0 |
| Applicants: | 7 |
| NDAs: | 7 |
| Finished Product Suppliers / Packagers: | 12 |
| Raw Ingredient (Bulk) Api Vendors: | 117 |
| Clinical Trials: | 9 |
| Patent Applications: | 3,737 |
| Drug Prices: | Drug price information for METHAZOLAMIDE |
| DailyMed Link: | METHAZOLAMIDE at DailyMed |
Recent Clinical Trials for METHAZOLAMIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Waterloo | Phase 4 |
| Wilderness Medical Society | Phase 4 |
| University of British Columbia | Phase 4 |
Medical Subject Heading (MeSH) Categories for METHAZOLAMIDE
Anatomical Therapeutic Chemical (ATC) Classes for METHAZOLAMIDE
US Patents and Regulatory Information for METHAZOLAMIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ani Pharms | METHAZOLAMIDE | methazolamide | TABLET;ORAL | 040001-001 | Jun 30, 1993 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Bausch And Lomb Inc | METHAZOLAMIDE | methazolamide | TABLET;ORAL | 207438-001 | Oct 5, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Applied Anal | METHAZOLAMIDE | methazolamide | TABLET;ORAL | 040011-002 | Jul 17, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sandoz | METHAZOLAMIDE | methazolamide | TABLET;ORAL | 040036-002 | Jun 30, 1993 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
